BIOAVAILABILITY OF NAPROXEN SODIUM AND ITS RELATIONSHIP TO CLINICAL ANALGESIC EFFECTS

被引：77

作者：

SEVELIUS, H

RUNKEL, R

SEGRE, E

BLOOMFIELD, SS

机构：

[1] SYNTEX RES CORP,INST PHARMACOL,PALO ALTO,CA 94304

[2] SYNTEX RES CORP,INST METAB,PALO ALTO,CA 94304

[3] UNIV CINCINNATI,MED CTR,DIV CLIN PHARMACOL,CINCINNATI,OH 45221

来源：

关键词：

D O I：

10.1111/j.1365-2125.1980.tb01753.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：259 / 263

页数：5

共 16 条

[1]

BELLVILLE JW, 1968, CLIN PHARMACOL THER, V9, P290

[2]

BLOOMFIELD SS, 1977, CLIN PHARMACOL THER, V21, P414

[3]

BLOOMFIELD SS, 1978, 7TH INT C PHARM IUPH

[4]

HOUDE RW, 1960, CLIN PHARMACOL THER, V1, P163

LEVY, G .

[6] PHARMACOKINETICS OF SALICYLATE ELIMINATION IN MAN [J].

LEVY, G .

[7]

MAHLER DL, 1976, CLIN PHARMACOL THER, V19, P18

[8]

ROSZKOWSKI A P, 1973, Scandinavian Journal of Rheumatology Supplement, V2, P12

[9]

RUEDY J, 1973, Scandinavian Journal of Rheumatology Supplement, V2, P56

[10]

RUEDY J, 1973, Scandinavian Journal of Rheumatology Supplement, V2, P60